Medy-Tox Inc. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
39,141
75,892
88,505
133,256
181,239
Cost of Goods Sold (COGS) incl. D&A
6,038
8,585
16,185
26,443
38,550
Gross Income
33,103
67,308
72,320
106,813
142,689
SG&A Expense
16,072
16,721
20,498
31,381
51,698
EBIT
16,756
50,204
51,662
75,172
90,160
Unusual Expense
627
1,918
474
1,713
3,745
Non Operating Income/Expense
276
20
545
396
4,644
Interest Expense
166
106
106
919
2,063
Pretax Income
16,797
53,861
52,020
75,754
88,420
Income Tax
2,494
10,234
9,670
15,766
15,254
Equity in Affiliates
-
-
57
757
-
Consolidated Net Income
14,304
43,628
42,293
59,231
73,167
Net Income
14,304
43,628
42,293
59,231
73,279
Net Income After Extraordinaries
14,304
43,628
42,293
59,231
73,279
Net Income Available to Common
14,304
43,628
42,293
59,231
73,279
EPS (Basic)
2,633.00
8,108.00
7,926.00
11,132.00
13,856.00
Basic Shares Outstanding
5
5
5
5
5
EPS (Diluted)
2,632.53
8,107.61
7,926.09
11,132.45
13,856.27
Diluted Shares Outstanding
5
5
5
5
5
EBITDA
18,627
53,062
55,507
79,921
98,372
Other Operating Expense
275
382
160
260
832
Non-Operating Interest Income
559
1,825
393
184
358
Minority Interest Expense
-
-
-
-
113
Equity in Affiliates (Pretax)
-
-
-
-
933
About Medy-Tox
View Profile
